Publication

3D quantification of changes in pancreatic islets in mouse models of diabetes type I and II

Disease Models & Mechanisms 13(12):dmm045351, 2020

Roostalu U, Skytte JL, Salinas CG, Klein T, Vrang T, Jelsing J, Hecksher-Sørensen J

Share this page

Resource Library

Related resources

Nephroprotective effects of semaglutide as mono- and combination treatment with lisinopril in a mouse model of hypertension-accelerated diabetic kidney disease

Chronic peptide-based GIP receptor inhibition exhibits modest glucose metabolic changes in mice when administered either alone or combined with GLP-1 agonism

GIPR Agonism Inhibits PYY-Induced Nausea-Like Behavior

New insights into disease progression and human translatability of the GAN DIO-NASH mouse

For further information

Contact us

Gubra

Hørsholm Kongevej 11B
2970 Hørsholm
Denmark

+45 3152 2650